NASDAQ: AHCO
Adapthealth Corp Stock

$9.71+0.17 (+1.78%)
Updated Dec 11, 2024
AHCO Price
$9.71
Fair Value Price
N/A
Market Cap
$1.31B
52 Week Low
$6.43
52 Week High
$11.90
P/E
-5.92x
P/B
0.86x
P/S
0.46x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.26B
Earnings
-$214.34M
Gross Margin
16.2%
Operating Margin
-2.46%
Profit Margin
-6.6%
Debt to Equity
1.94
Operating Cash Flow
$547M
Beta
0.79
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

AHCO Overview

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine AHCO's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

B
Value
C
Growth
C
Momentum
C
Sentiment
B
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
D
AHCO
Ranked
#24 of 126

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$28.81A
$11.58A
$51.49A
View Top Medical Device Stocks

Be the first to know about important AHCO news, forecast changes, insider trades & much more!

AHCO News

Overview

Due Diligence Score

Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AHCO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AHCO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AHCO is good value based on its book value relative to its share price (0.86x), compared to the US Medical Devices industry average (4.05x)
P/B vs Industry Valuation
AHCO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AHCO due diligence checks available for Premium users.

Valuation

AHCO price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-5.92x
Industry
36.96x
Market
29.76x

AHCO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.86x
Industry
4.05x
AHCO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AHCO's financial health

Profit margin

Revenue
$805.9M
Net Income
$22.9M
Profit Margin
2.8%
AHCO's Earnings (EBIT) of -$80.10M... subscribe to Premium to read more.
Interest Coverage Financials
AHCO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$4.5B
Liabilities
$2.9B
Debt to equity
1.94
AHCO's short-term assets ($683.79M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AHCO's long-term liabilities ($2.39B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AHCO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AHCO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$144.4M
Investing
-$54.2M
Financing
-$59.8M
AHCO's operating cash flow ($546.69M)... subscribe to Premium to read more.
Debt Coverage Financials

AHCO vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
AHCOB$1.31B+1.78%-5.92x0.86x
ESTAC$1.30B+7.49%-18.03x39.82x
AORTC$1.25B+0.30%-1,496.00x4.12x
ATECC$1.37B+0.41%-7.63x-1,008.61x
INMDB$1.43B+0.32%9.90x1.95x

Adapthealth Stock FAQ

What is Adapthealth's quote symbol?

(NASDAQ: AHCO) Adapthealth trades on the NASDAQ under the ticker symbol AHCO. Adapthealth stock quotes can also be displayed as NASDAQ: AHCO.

If you're new to stock investing, here's how to buy Adapthealth stock.

What is the 52 week high and low for Adapthealth (NASDAQ: AHCO)?

(NASDAQ: AHCO) Adapthealth's 52-week high was $11.90, and its 52-week low was $6.43. It is currently -18.4% from its 52-week high and 51.01% from its 52-week low.

How much is Adapthealth stock worth today?

(NASDAQ: AHCO) Adapthealth currently has 134,554,889 outstanding shares. With Adapthealth stock trading at $9.71 per share, the total value of Adapthealth stock (market capitalization) is $1.31B.

Adapthealth stock was originally listed at a price of $10.00 in Feb 16, 2018. If you had invested in Adapthealth stock at $10.00, your return over the last 6 years would have been -2.9%, for an annualized return of -0.49% (not including any dividends or dividend reinvestments).

How much is Adapthealth's stock price per share?

(NASDAQ: AHCO) Adapthealth stock price per share is $9.71 today (as of Dec 11, 2024).

What is Adapthealth's Market Cap?

(NASDAQ: AHCO) Adapthealth's market cap is $1.31B, as of Dec 12, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Adapthealth's market cap is calculated by multiplying AHCO's current stock price of $9.71 by AHCO's total outstanding shares of 134,554,889.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.